APOE and Alzheimer disease: Because most (13/22) of our samples were homozygous for the APOE ε3 allele, we generated a subset of our dataset that consisted entirely of APOE ε3/ε3 individuals (seven controls and six AD pathology, nine females and four males; 75,018 microglia nuclei).